Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients

Diabetes Care

Volumn 30, Issue 9, 2007, Pages 2349-2354

  Colussi, GianLuca ^a   Catena, Cristiana ^a   Lapenna, Roberta ^a   Nadalini, Elisa ^a   Chiuch, Alessandra ^a   Sechi, Leonardo A ^a  

^a UNIVERSITY OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; C PEPTIDE; GLUCOSE; HYDROCORTISONE; INSULIN;

ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; BODY MASS; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE METABOLISM; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METABOLIC CLEARANCE RATE; MULTIPLE REGRESSION; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL;

AGED; ALDOSTERONE; CROSS-SECTIONAL STUDIES; FEMALE; GLUCOSE; HUMANS; HYPERINSULINISM; HYPERTENSION; INSULIN RESISTANCE; MALE; MIDDLE AGED;

EID: 34548419736     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc07-0525     Document Type: Article

References (34)

1. Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, Shitrit A, Fuchs Z: Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest 75:809-817, 1985
2. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S: Insulin resistance in essential hypertension. N Engl J Med 317:350-357, 1987
3. Saad MF, Lillioja S, Nyomba BL, Castillo C, Ferraro R, De Gregorio M, Ravussin R, Knowler WC, Bennet PH, Howard BV: Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med 324:733-739, 1991
4. Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ: Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334:952-957, 1996
5. Grim CE, Cowley AW Jr, Hamet P, Gaudet D, Kaldunski ML, Kotchen JM, Krishnaswami S, Pausova Z, Roman R, Tremblay J, Kotchen TA: Hyperaldosteronism and hypertension: ethnic differences. Hypertension 45:766-772, 2005
6. Goodfriend TL, Calhoun DA: Resistant hypertension, obesity, sleep apnea, and aldosterone: theory and therapy. Hypertension 43:518-524, 2004
7. Vasan RS, Evans JC, Larson MG, Wilson PW, Meigs JB, Rifai N, Benjamin EJ, Levy D: Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N Engl J Med 351:33-41, 2004
8. Rossi GP, Boscaro M, Ronconi V, Funder JW: Aldosterone as a cardiovascular risk factor. Trends Endocrinol Metab 16:104-107, 2005
9. Goodfriend TL, Egan BM, Kelley DE: Plasma aldosterone, plasma lipoproteins, obesity and insulin resistance in humans. Prostaglandins Leukot Essent Fatty Acids 60:401-405, 1999
10. Catena C, Lapenna R, Baroselli S, Nadalini E, Colussi GL, Novello M, Favret G, Melis A, Cavarape A, Sechi LA: Insulin sensitivity in patients with primary aldosteronism: a follow-up study. J Clin Endocrinol Metab 91:3457-3463, 2006
11. Bochud M, Nussberger J, Bovet P, Maillard MR, Elston RC, Paccaud F, Shamlaye C, Burnier M: Plasma aldosterone is independently associated with the metabolic syndrome. Hypertension 48:239-245, 2006
12. Kidambi S, Kotchen JM, Grim CE, Raff H, Mao J, Singh RJ, Kotchen TA: Association of adrenal steroids with hypertension and the metabolic syndrome in blacks. Hypertension 49:1-8, 2007
13. Sechi LA, Kronenberg F, De Carli S, Falleti E, Zingaro L, Catena C, Utermann G, Bartoli E: Association of serum lipoprotein (a) levels and apolipoprotein (a) size polymorphism with target-organ damage in arterial hypertension. JAMA 277:1689-1695, 1997
14. Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, Gomez-Sanchez CE, Veglio F, Young WF Jr: Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 89:1045-1050, 2004
15. Sechi LA, Catena C, Zingaro L, Melis A, De Marchi S: Abnormalities of glucose metabolism in patients with early renal failure. Diabetes 51:1226-1232, 2002
16. Sechi LA, Melis A, Tedde R: Insulin hypersecretion: a distinctive feature between essential and secondary hypertension. Metabolism 41:1261-1266, 1992
17. Sealey JE, Gordon RD, Mantero F: Plasma renin and aldosterone measurements in low renin hypertensive states. Trends Endocrinol Metab 16:86-91, 2005
18. Reaven GM: Insulin resistance/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease. J Clin Endocrinol Metab 88:2399-2403, 2003
19. Egan BM, Papademetriou V, Wofford M, Calhoun D, Fernandes J, Riehle JE, Nesbitt S, Michelson E, Julius S: Metabolic syndrome and insulin resistance in the TROPHY sub-study: contrasting views in patients with high-normal blood pressure. Am J Hypertens 18:3-12, 2005
20. Giacchetti G, Sechi LA, Rilli S, Carey RM: The renin-angiotensin- aldosterone system, glucose metabolism and diabetes. Trends Endocrinol Metab 3:120-126, 2005
21. Corry DB, Tuck M: The effect of aldosterone on glucose metabolism. Curr Hypertens Rep 5:106-109, 2003
22. Henquin JC: Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 49:1751-1760, 2000
23. Plavinik FL, Rodrigues CI, Zanella MT, Ribeiro AB: Hypokalemia, glucose intolerance, and hyperinsulinemia during diuretic therapy. Hypertension 19(Suppl. 2):26-29, 1992
24. Kraus D, Jager J, Meier B, Fasshauer M, Klein J: Aldosterone inhibits uncoupling protein-1, induces insulin resistance, and stimulates proinflammatory adipokines in adipocytes. Horm Metab Res 37:455-459, 2005
25. Petrasek D, Jensen G, Tuck M, Stern N: In vitro effects of insulin on aldosterone production in rat zona glomerulosa cells. Life Sci 50:1781-1787, 1992
26. Haenni A, Reneland R, Lind L, Lithell H: Serum aldosterone changes during hyperinsulinemia are correlated to body mass index and insulin sensitivity in patients with essential hypertension. J Hypertens 19:107-112, 2001
27. Eckel RH, Grundy SM, Zimmet PZ: The metabolic syndrome. Lancet 365:1415-1428, 2005
28. Goodfriend TL, Ball DL, Egan BM, Campbell WB, Nithipatikom K: Epoxy-keto derivative of linolenic acid stimulates aldosteronesecretion. Hypertension 43:358-363, 2004
29. Ehrhart-Bornstein M, Lamounier-Zepter V, Schraven A, Lagenbach J, Willenberg HS, Barthel A, Hauner H, McCann SM, Scherbaum WA, Bornstein SR: Human adipocytes secrete mineralocorticoid-releasing factors. Proc Natl Acad Sci U S A 100:14211-14216, 2003
30. Rocchini AP, Moorehead C, DeRemer S, Goodfriend TL, Ball DL: Hyperinsulinemia and the aldosterone and pressor responses to angiotensin II. Hypertension 15:861-866, 1990
31. Rocchini AP, Key J, Bondie D, Chico R, Moorehead C, Katch V, Martin M: The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med 321:580-585, 1989
32. Huang DY, Boini KM, Osswald H, Friedrich B, Artunc F, Ullrich S, Rajamanickam J, Palmada M, Wulff P, Kuhl D, Vallon V, Lang F: Resistance of mice lacking the serum- and glucocorticoid-inducible kinase SGK1 against salt-sensitive hypertension induced by a high-fat diet. Am J Physiol Renal Physiol 29:F1264-F1273, 2006
33. Goodfriend TL, Egan BM, Kelley DE: Aldosterone in obesity. Endocr Res 24:789-796, 1998
34. Rocchini AP, Katch VL, Grekin R, Moorehead C, Anderson J: Role for aldosterone in blood pressure regulation of obese adolescents. Am J Cardiol 57:613-618, 1986